期刊文献+

WNK_3激酶高表达对白介素-1β诱导HEK293细胞凋亡的保护作用 被引量:4

The protective effect of WNK_3 kinase on apoptosis in HEK293 cell induced by interleukin-1β
在线阅读 下载PDF
导出
摘要 目的:观察WNK_3激酶高表达对白介素-1β(IL-1β)诱导人胚肾细胞(HEK293细胞)凋亡的作用。方法:HEK293细胞分为3组:Vector+NS组、Vector+IL-1β组和WNK_3+IL-1β组。Vector+NS组、Vector+IL-1β组转染对照Vector,WNK_3+IL-1β组转染WNK_3。药物干预时,Vector+NS组加入等量0.9%氯化钠溶液,Vector+IL-1β组、WNK_3+IL-1β组加入10 ng/m L IL-1β。分别于培养0、12、24、36和48 h时,采用CCK-8试剂盒检测细胞活性。孵育0、18、36 h时应用Western blot法检测Caspase-3、cleaved Caspase-3、Caspase-9、cleaved Caspase-9等凋亡蛋白。在IL-1β干预0、30、60 min时采用Western blot法检测JNK通路蛋白。结果:Vector+IL-1β组在给药后细胞活性逐渐下降,在48 h达到最低值,WNK_3+IL-1β组下降幅度较缓和,与同时间点Vector+IL-1β组比较细胞活性回升,在48 h时差异有统计学意义(P<0.01)。IL-1β孵育后cleaved Caspase-3和cleaved Caspase-9表达量增加。与36 h的Vector+IL-1β组比较,WNK_3+IL-1β组的cleaved Caspase-3显著减少,2组的cleaved Caspase-9在18 h及36 h时差异亦存在统计学意义(P<0.05)。WNK_3转染后p-JNK的表达水平较未转染WNK_3组的上升幅度降低(P<0.05)。结论:IL-1β诱导HEK293细胞活性下降,而转染WNK_3质粒可以有效逆转部分细胞活性。WNK_3激酶通过减少JNK的磷酸化抑制Caspase途径的活化,减少细胞凋亡,起到在不利条件下保护肾脏细胞的作用。 Objective: To observe the effect of high expression of WNK3 on apoptosis in HEK293cells induced by interleukin-1β. Methods: The HEK293 cells were divided into 3 groups (Vector+NS group, Vector+IL-1β group and WNK3+IL-1β group), then tansfection was performed. Liposome 2000 was added to the 1st and 2na group with PCMV-HA-Vector as the blank and negative control respectively; WNK3 was added to the 3ra group. After treated with 10 ng/mL IL-1β (the 2na and 3rd group) or the same amount of normal saline (the 1st group), the CCK8 analysis was performed for the detection of cell activity after incubation for 0 h, 12 h, 24 h, 36 h and 48 h at 37 ℃ respectively. Cell proteins were collected after 0 h, 18 h and 36 h incubation respectively for detection of Caspase-3, Cleaved Caspase-3, Caspase-9, Cleaved Caspase-9. In addition, cell protein were collected 0 min, 30 min and 60 min after the treatment oflL-1β for JNK detection. Results: No significant difference of cell activity was observed in the Vector+NS group within 48 h. In the Vector+IL-1β group, cell activity began to decline soon after administration. Significant difference could be found after 24 h and the cell activity reached the lowest at 48 h (P〈0.01). Cell activity of WNK3+IL-1β group declined in a moderate manner and the significant difference appeared at 36 h and 48 h when comparing with that at 0 h in the same group (both P〈0.05 ). However, in comparison with the Vector+IL-1β group at the same time point, cell activity of WNK3+IL- 1β group was still a little higher and the significant difference could be observed at 48 h (P〈0.01). The expression of Caspase-9 and Caspase-3 began to decline 18 h after the administration with an increasing peak of cleaved Caspase-9 which decreased slightly at 36 h. An obvious cleaved Caspase-3 could also be observed 36 h after theadministration. In the WNK3+IL-1β group, the decline of Caspase-3 was more moderate when comparing with that in the Vector+IL-1β group. A small quantity of cleaved Caspase-3 could be detected and showed an statistical significance in comparison with that of the same group at 0 h (P〈0.05) with the WNK3; the expression of p-JNK declined but t-JNK did not change. Conclusion: IL-1β may decrease activity of HEK293 cells while transfection of WNK3 may partly reverse this affection of IL-113. The over expression of WNK3 may inhibit the activation of JNK pathways induced by IL-1β, decrease the activation of Caspase pathway to reduce apoptosis, and finally pro- tect the kidney cells under adverse conditions.
出处 《温州医科大学学报》 CAS 2016年第1期1-6,共6页 Journal of Wenzhou Medical University
基金 国家自然科学基金青年基金资助项目(81200513) 钱江人才项目(2011R10049) 温州市科技局科研基金资助项目(H20110014)
关键词 WNK3 JNK 白介素-1Β 肾脏 凋亡 WNK3 JNK IL-1β kidney apoptosis
  • 相关文献

参考文献16

  • 1ZHOU B, WANG D, FENG X, et al. WNI~ inhibits NCC protein expression through MAPK ERK1/2 signaling path- way[J]. Am J Physiol Renal Physiol, 2012, 302(5): F533- 539.
  • 2CHENG L, WU Q, KORTENOEVEN M L, et al. A systems level analysis of vasopressin-mediated signaling networks in kidney distal convoluted tubule cells[J]. Sci Rep, 2015, 5(4): 12829.
  • 3GLOVER M, O'SHAUGHNESSY K M. SPAK and WNK kinases: a new target for blood pressure treatment?[J]. Curt Opin Nephrol Hypertens, 2011, 20(1): 16-22.
  • 4MCDONOUGH A A. Mechanisms of proximal tubule so- dium transport regulation that link extracellular fluid volume and blood pressure[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 298(4): R851-861.
  • 5VERiSSIMO F, SILVA E, MORRIS J D, et al. Protein ki- nase WNK3 increases cell survival in a caspase-3-dependent pathway[J]. Oncogene, 2006, 25(30): 4172-4182.
  • 6ZHANG Z H, XU X H, XIANG Z H, et al. LINGO-1 re- ceptor promotes neuronal apoptosis by inhibiting WNK3 ki- nase activity[J]. J Biol Chem, 2013, 288(17): 12152-12160.
  • 7王玉,李晓玫,王海燕.白介素-1β通过JNK/p38信号转导通路调控肾系膜细胞表达α-平滑肌肌动蛋白[J].生理学报,2002,54(3):244-250. 被引量:33
  • 8WANG L, GAI P, XU R, et al. Shikonin protects chondro-cytes from interleukin-lbeta-induced apoptosis by regulat- ing PI3K/Akt signaling pathway[J]. Int J Clin Exp Pathol, 2015, 8(1): 298-308.
  • 9徐宁,王德选.WNK3激酶与肾小管钠离子转运[J].国际泌尿系统杂志,2015,35(1):123-126. 被引量:1
  • 10LAGNAZ D, ARROYO J P, CI4~VEZ-CANALES M, et al. WNK3 abrogates the NEDD 4-2-mediated inhibition of the renal Na+-Cl-cotransporter[J]. Am J Physiol Renal Physiol, 2014, 307 (3): F275-286.

二级参考文献28

  • 1Xu B, English JM, Wilsbacher JL, et al. WNK1 ,a novel mamma- lian serine/threonine protein kinase lacking the catalytic in subdo- main II[ J ]. J, Biol Chem,2000,275 : 16795 - 16801.
  • 2McCormick JA, Ellison H. The WNKs: atypical protein kinases with pleiotropic actions[ J]. Physiol Rev,2011,91 ( 1 ) : 177 - 219.
  • 3San - Cristobal P, Ponce - Coria J, Vazquez N, et al. WNK3 and WNK4 amino - terminal domain defines their effect on the renal Na + - C1 - cotransporter [ J ]. Am J Physiol Renal Physiol, 2008, 295(4) :1199 - 1206.
  • 4Holden S, Cox J, Raymond FL. Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 ( PRKWNK3 ) [ J]. Gene, 2004,335 : 109 - 119.
  • 5Glover M, Zuber AM, O Shaughnessy KM. Renal and brain iso- forms of WNK3 have opposite effects on NCCT expression [ J ]. J Am Soc Nephro1,2009,20(6) :1314 - 1322.
  • 6Cruz - Rangel S, Melo Z, Vazquez N, et al. Similar effects of all WNK3 variants on SLC12 cotransporters [ J ]. Am J Physiol Cell Physiol, 2011,301 ( 3 ) :601 - 608.
  • 7Cruz - Rangel S, Gamba G, Ramos - Mandujano G, et al. Influ- ence of WNK3 on intracellular chloride concentration and volume regulation in HEK293 cells[J]. Pflugers Arch,2012,464(3):317 - 330.
  • 8Zhang Zhaohuan, Xu Xiaohui, Xiang Zhenghua, et al. LINGO- 1 receptor promotes neuronal apoptosis by inhibiting WNK3 kinase activity [ J ]. J Biol Chem, 2013,288 ( 17 ) : 12152 - 12160.
  • 9Verissimo F, Silva E, Pepperkok R,et al. Protein kinase WNK3 increases cell survival in a easpase - 3 - dependent pathway [ J ]. Oneogenc ,2006,25 (30) :4172 - 4182.
  • 10Haas BR, Cuddapah VA. With - No - Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume [J]. Am J Physiol Cell Physial, 2011. 301 (5) : 1150 - 1160.

共引文献32

同被引文献20

  • 1KOURLAS P J, STROUT M P, BECKNELL B, et al. Identi- fication of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia[J]. Proc Natl Acad Sci U S A, 2000, 97 (5): 2145-2150.
  • 2REUTHER G W, LAMBERT Q T, BOODEN M A, et al. Leukemia-associated Rho guanine nucleotide exchange fac- tor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA[J]. J Biol Chem, 2001, 276(29): 27145-27151.
  • 3CANCELAS J A, LEE A W, PRABHAKAR R, et al. Rac GTPases differentially integrate signals regulating hemato- poietic stem cell localization[J]. Nat Med, 2005, 11(8): 886- 891.
  • 4GU Y, FILIPPI M D, CANCELAS J A, et al. Hematopoietic cell regulation by Racl and Rac2 guanosine triphosphatases [J]. Science, 2003, 302(5644): 445-449.
  • 5YANG F C, ATKINSON S, GU Y, et al. Rac and Cdc42 GT- Pases control hematopoietic stem cell shape, adhesion, mi-gration, and mobilization[J]. Proc Natl Acad Sci U S A, 2001, 98 (10): 5614-5618.
  • 6YANG L, WANG L, GEIGER H, et al. Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow[J]. Proc Natl Acad Sci U S A, 2007, 104 (12): 5091-5096.
  • 7MOLL/P R, PRADHAN M B, ADVANI S H, et al. RhoA: a therapeutic target for chronic myeloid leukemia[J]. Mol Cancer, 2012, 11: 16.
  • 8LUCIANI M G, HUTCHINS J R, ZhELEVA D, et al. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A[J]. J Mol Biol, 2000, 300(3): 503- 518.
  • 9ALSAYEGH K N, GADEPALLI V S, IYER S, et al. Knock- down of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence[J]. PLoS One, 2015, 10(3): e0120782.
  • 10LE X F, CLARET F X, LAMMAYOT A, et al. The role of cyclin-dependent kinase inhibitor p27Kipl in anti-HER2 an- tibody-induced G1 cell cycle arrest and tumor growth inhi- bition[J]. J Biol Chem, 2003, 278(26): 23441-23450.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部